Current and historical gross margin, operating margin and net profit margin for Veracyte (VCYT) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Veracyte net profit margin as of June 30, 2018 is -38.69%.
|Veracyte Annual Profit Margin Summary
|Veracyte Quarterly Profit Margin Summary
||Medical Instruments Manufacturing
Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also developing Afirma Malignant GEC test. It serves endocrinologists, radiologists, and head and neck specialists. Veracyte, Inc. is headquartered in South San Francisco, California.